Total parenteral nutrition (TPN) supplies for the department of pharmacy
Active Awarded Last action
- Contract number
- HT001426FE016
- Awardee
-
Central Admixture Pharmacy Services, Inc. UEI NDPWXJSVYVH9
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $200,000
Award facts
- Contract value 100% obligated
- $200,000.00 Current and potential, with all options
- Completion date 76% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20889, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at $200,000 to Central Admixture Pharmacy Services, Inc. (Caps) for Total Parenteral Nutrition (TPN) supplies supporting the Department of Pharmacy. The contract, effective January 16, 2026, with an ultimate completion date of January 15, 2027, utilizes a firm fixed-price arrangement with no set-aside designation. Performance will take place at Bethesda, Maryland, supporting federal healthcare operations. As a pharmaceutical compounding specialist headquartered in Irvine, California, Caps provides patient-specific compounded sterile preparations including TPN solutions, sterile admixtures, intravenous mixtures, and lipid emulsions to multiple federal healthcare agencies.
This award represents a task order under the Defense Health Agency's $6.5 million BPA for compounded admixture medicines and total parenteral nutrition solutions, which has supported multiple orders since July 2021. Caps is classified as a large business entity and maintains an established track record with federal healthcare systems, including the Department of Veterans Affairs, National Institutes of Health, Indian Health Service, and Department of the Army Medical Command. The company holds approximately $18.3 million in aggregate authorized ceiling values across multiple indefinite delivery vehicles with federal agencies, reflecting sustained demand for its specialized pharmaceutical compounding services essential to critical patient care applications across federal healthcare facilities.
Quick answers
Who was awarded contract HT001426FE016?
HT001426FE016 was awarded to Central Admixture Pharmacy Services, Inc. by Defense Health Agency (Department of Defense) on January 16, 2026.
How much is contract HT001426FE016 worth?
The government has obligated $200,000 on HT001426FE016.
Is contract HT001426FE016 an order under another contract?
Yes. HT001426FE016 is a BPA call under HT001421A0009, a blanket purchase agreement.
Was contract HT001426FE016 competed?
The extent of competition for HT001426FE016 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award